Φορτώνει......

Hormone Receptor Status Influences the Locoregional Benefit of Trastuzumab in Patients with Non-metastatic Breast Cancer

BACKGROUND: Previous studies have shown that hormone receptor (HR) and HER2 status influence the outcome of locoregional treatments. However, the interrelationship of these factors with trastuzumab is unclear. We sought to determine the role of HR and HER2 status on the locoregional benefit of trast...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Kim, Michelle M., Dawood, Shaheenah, Allen, Pamela, Sahin, Aysegul A., Woodward, Wendy A., Smith, Benjamin D., Strom, Eric A., Hunt, Kelly K., Meric-Bernstam, Funda, Gonzalez-Angulo, Ana Maria, Buchholz, Thomas A.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: 2012
Θέματα:
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3888990/
https://ncbi.nlm.nih.gov/pubmed/22511276
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.27502
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!